Luke Forryan

Since joining Kirkland, Luke has been involved in the following matters:

• EQT-led consortium on the £4.5 billion recommended cash offer for Dechra Pharmaceuticals PLC.
• AXA IM on the sale of Data4 to Brookfield.
• Warburg Pincus and ARCHIMED on the sale of Polyplus to Sartorius, a life science group.
• Thoma Bravo in its investment in LOGEX, a leading healthcare analytics provider and the inaugural investment by Thoma Bravo’s Europe-based team.
• Benedict Real Estate Bidco Limited, a subsidiary of one of Brookfield's real estate private funds, on the recommended cash offer for the entire issued and to be issued share capital of Hibernia REIT.
• The Carlyle Group, on the proposed acquisition of ekaterra, Unilever’s global tea business.
• Gazit Hercules 2020 Limited (Newco) on the definitive merger agreement for a recommended cash acquisition of Atrium European Real Estate Limited.
• Groupe Bruxelles Lambert in its acquisition of Affidea, the leading provider of medical diagnostic services in Europe.
• Sani/Ikos Group in its strategic partnership agreement with GIC.

Prior to joining Kirkland, Luke was involved in the following matters:

• Blackstone on the acquisition of CRH Europe Distribution, a building materials distribution platform in continental Europe, from CRH plc for an enterprise value of €1.64 billion.
• Chrysaor, a leading UK oil & gas independent, in its acquisition of ConocoPhillips’ UK business for $2.675 billion.
• BCI in its investment in a European gas distribution network.
• The Mandated Lead Arrangers on the financing of TDR Capital LLP’s £6.8 billion acquisition of ASDA.
• A bidder on the proposed acquisition of ITP Aero from Rolls-Royce.
• abrdn on the sale of a portfolio of LP interests to Golding Capital.

Clifford Chance LLP, London

• Trainee Solicitor, 2019–2021